论文部分内容阅读
目的：探索复方氯唑西林胶囊治疗幽门螺旋杆菌感染性胃炎的疗效。方法：幽门螺旋杆菌感染性胃炎５６例，分成复方氯唑西林胶囊组２４例（男性１５例，女性９例，年龄５１±ｓ１０ａ），用复方氯唑西林胶囊（氨苄西林和氯唑西林１：１）０．５ｇ，ｐｏ，ｔｉｄ，共４ｗｋ；庆大霉素组３２例（男性２１例，女性１１例，年龄５３±１１ａ），用庆大霉素片或针剂８万Ｕ，ｐｏ，ｔｉｄ，共４ｗｋ；结果：总有效率复方氯唑西林胶囊组８３％，庆大霉素组９１％（Ｐ＞０．０５），结论：为治疗幽门螺旋杆菌感染性胃炎提供了新途径。
Objective: To explore the efficacy of compound cloxacillin capsule in the treatment of Helicobacter pylori infection gastritis. Methods: Fifty-six patients with Helicobacter pylori gastritis were divided into 24 groups (15 males and 9 females, age 51 ± s10a) with cloxacillin co-trimoxazole capsules (with ampicillin and cloxacillin 1: 1) 0.5g, po, tid, a total of 4wk; gentamicin group of 32 patients (21 males and 11 females, age 53 ± 11a), with gentamicin tablets or injections 80,000 U, po, tid , Total 4wk; Results: The total effective rate of cloxacillin capsule group 83%, 91% of the gentamicin group (P> 0.05), Conclusion: for the treatment of Helicobacter pylori infection gastritis provides a new way.